Cover 2 Resources
Cover 2 Resources
Ep. 228 - Pharma. Company Exposed in Boston: A Conversation with Palm Beach Post Reporters Pt. 2
Ep. 228 - Pharma. Company Exposed in Boston: A Conversation with Palm Beach Post Reporters Pt. 2
Ep. 228 - Pharma. Company Exposed in Boston: A Conversation with Palm Beach Post Reporters Pt. 2
Friday 15th February 2019
Uncover the shocking tactics of Insys Therapeutics in this Cover2 Resources episode. Explore how pharma companies prioritize profits over people.
29 minutes
Informative
Thought-provoking
Raw
Engaging
Eye-opening
About this podcast
Overview:
Categories:
Innovative Treatments & Recovery Paths
Family Recovery from Addiction
Sobriety Toolkit
Body & Mind
Navigating Intimate Relationships
Links:
Visit site
Episodes:
284 (View all)
Do you want to link to this podcast?
Get the buttons here!Exposing Deceptive Pharma Practices: Inside the Insys Therapeutics Scandal
To this day, judges presiding over landmark cases such as the racketeering case against Insys Therapeutics and the multi-district litigation case of over municipalities and tribes against the pharmaceutical industry have an opportunity to stop Purdue Pharma and the others in the industry from choosing profits over people.
Imagine a pharmaceutical company using a rap video to persuade doctors to prescribe higher doses of a potent opioid. Sounds like a plot twist, right? Well, this episode of Cover2 Resources takes you right into the heart of the Insys Therapeutics racketeering case in Boston. Join host Greg McNeil as he chats with Palm Beach Post reporters John Pacenti and Pat Beall, who bring to light the jaw-dropping tactics used by Insys to push their liquid opioid, Subsys.
You’ll hear an actual clip from the company’s own rap video that glorifies ‘titration’ and new patient acquisition, revealing just how far they went to boost sales. But that's just the tip of the iceberg. This conversation dives deep into the shady sales practices that Purdue Pharma pioneered over two decades ago and how companies like Insys have perpetuated them. Remember Purdue Pharma's 2007 guilty plea for misbranding and deceptive marketing?
The charges were reduced, thanks in part to Rudy Giuliani, but the story didn't end there. Fast forward to January, and former Insys executives are facing trial for similar deceptions. John Pacenti exposes a corrupt operation willing to do anything for profit, from manipulating doctors to giving away free opioid savings cards.
This episode doesn't just spotlight the culprits; it also examines the broader impact of opioid addiction on communities and the crucial role judges play in holding these companies accountable. If you're curious about how pharmaceutical companies put profits over people and what can be done to stop them, this episode is a must-listen.